St. Luke Episcopal Hospital is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
St. Luke Episcopal Hospital has participated in 3 clinical trials.
Therapeutic areas: Primary Sclerosing Cholangitis (PSC), Hepatitis C, Chronic, Liver Fibrosis Due to NASH.
Sponsors: Gilead Sciences.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
St. Luke Episcopal Hospital has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St. Luke Episcopal Hospital has 3 clinical trials on record. Their work covers Primary Sclerosing Cholangitis (PSC), Hepatitis C, Chronic, Liver Fibrosis Due to NASH.
St. Luke Episcopal Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.